Research News

NIHR newsletter for patients and the public- Winter 2017

Friday, 17 February 2017 13:35

Over the coming months the NIHR will be bringing you public involvement and engagement news, views and good practice from across the NIHR. They hope it will inform and inspire you, as well as stimulate new thinking and ideas across the community. You may have seen that the NIHR recently launched an exciting and innovative new poster campaign to raise public awareness of the big part the public play in making world-class research happen. Learn more about the campaign as well as about guidance, involvement in research, student challenges and more in the newsletter.

A Researcher’s Breakthrough Moment

Friday, 17 February 2017 09:51

The Kenneth Rainin Foundation posted a video about a breakthrough moment for Dr. Gwendalyn Randolph. This pioneering researcher was recently awarded a Synergy Award from the Foundation. Her cutting-edge instincts led to a novel technique and the ability to peer more deeply into the workings of Crohn's disease.

Rainin Foundation awards $750,000 for IBD research

Friday, 17 February 2017 09:31

On 10 Feb 2017, the Kenneth Rainin Foundation announced that it has awarded $750,000 for Inflammatory Bowel Disease (IBD) research through its Synergy Award program. The Rainin Foundation funds scientific projects that have the potential to yield transformative discoveries and major insights into predicting and preventing IBD. Further details of the projects and awards can be found in their blog. The Synergy Awards are intended to foster collaboration. The Synergy Award programme is one of three grant programmes the Rainin Foundation offers for IBD-related research.

TRITON grant announcement

Wednesday, 15 February 2017 17:21

Professor Spiller and a team of experts from the Neurogastroenterology & Motility Section of the British Society of Gastroenterology who are based in 12 major research centres in the UK have been awarded a £2.1M grant from the National Institute of Health Research Efficacy and Mechanism Evaluation (NIHR EME) Programme to perform a clinical trial entitled "Treatment of IBS with diarrhoea with Titrated Ondansetron (TRITON)”. The trial will be coordinated from the Leeds Clinical Trials Research Unit and the mechanistic studies will involve specialist centres in Leeds, University College London and Barts and the London Hospital. Recruitment is expected to start in autumn 2017.

The trial offers a great opportunity for two specialist registrars to obtain a higher degree in the rapidly expanding field of neurogastroenterology. The trial will include studies of how ondansetron affects bowel motility and sensitivity. Understanding how ondansetron works will improve our ability to predict who will respond and will inform the development of new treatments for this common and distressing condition. One registrar will be based at QMC, Nottingham and the other at QMUL, London; both are expected to start their fully supported OOP work in September 2017. The posts will be advertised soon with full information on how to apply.

Page 11 of 41